Evidence map›Paper›PMID 26838722›Full record

ArticlemBio2016

The NADase-Negative Variant of the Streptococcus pyogenes Toxin NAD⁺ Glycohydrolase Induces JNK1-Mediated Programmed Cellular Necrosis.

Sukantha Chandrasekaran, Michael G Caparon

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Structure of the Streptococcus pyogenes NADJournal of bacteriology · 2022
    Article
  2. Pathogens (Basel, Switzerland) · 2021
    Review
  3. Frontiers in cellular and infection microbiology · 2021
    Article
  4. Nicotinamide Increases Intracellular NADFrontiers in microbiology · 2020
    Article
  5. Article
  6. Review
  7. Review
  8. Group AFrontiers in cellular and infection microbiology · 2019
    Article
  9. Group AFrontiers in cellular and infection microbiology · 2018
    Article
  10. NAD-Glycohydrolase Depletes Intracellular NADFrontiers in microbiology · 2018
    Article
  11. Binding of NADmBio · 2017
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sukantha ChandrasekaranDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Michael G CaparonDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA caparon@wusm.wustl.edu.
Washington University in St. Louis · US

Funding

Cytolysin-mediated translocation in S.pyogenes virulenceR01AI064721 · NIAID · WASHINGTON UNIVERSITY · PI CAPARON, MICHAEL G. · 2005 to 2014
$3.3M
NIAID NIH HHS AI064721NIAID NIH HHS R01 AI064721
6 · The paper itself

Abstract

unlabelledVirulence factors are often multifunctional and contribute to pathogenesis through synergistic mechanisms. For the human pathogen Streptococcus pyogenes, two factors that act synergistically are the S. pyogenes NAD(+) glycohydrolase (SPN) and streptolysin O (SLO). Through distinct mechanisms, SLO forms pores in host cell membranes and translocates SPN into the host cell cytosol. Two natural variants of SPN exist, one that exhibits NADase activity and one that lacks this function, and both versions are translocated and act in concert with SLO to cause an accelerated death response in epithelial cells. While NADase(+) SPN is known to trigger a metabolic form of necrosis through the depletion of NAD(+), the mechanism by which NADase(-) SPN induces cell death was unknown. In the studies described here, we examined the pathway of NADase(-) cell death through analysis of activation patterns of mitogen-activated protein kinases (MAPKs). S. pyogenes infection resulted in activation of members of three MAPK subfamilies (p38, ERK, and JNK). However, only JNK was activated in an SLO-specific manner. NADase(-) SPN induced necrosis in HeLa epithelial cells associated with depolarization of mitochondrial membranes, activation of NF-κB, and the generation of reactive oxygen species. Remarkably, RNA interference (RNAi) silencing of JNK protected cells from NADase(-)-SPN-mediated necrosis, suggesting that NADase(-) SPN triggers a form of programmed necrosis dependent on JNK signaling. Taken together, these data demonstrate that SPN acts with SLO to elicit necrosis through two different mechanisms depending on its NADase activity, i.e., metabolic (NADase(+)) or programmed (NADase(-)), leading to distinct inflammatory profiles. IMPORTANCE: Many bacterial pathogens produce toxins that alter how infected host cells interact with the immune system. For Streptococcus pyogenes, two toxins, a NAD(+) glycohydrolase (SPN) and streptolysin O (SLO), act in combination to cause infected cells to die. However, there are two natural forms of SPN, and these variants cause dying cells to produce different types of signaling molecules. The NADase(+) form of SPN kills cells by depleting reserves of NAD(+) and cellular energy. The other form of SPN lacks this activity (NADase(-)); thus, the mechanism by which this variant induces toxicity was unknown. Here, we show that infected cells recognize NADase(-) SPN through a specific signaling molecule called JNK, which causes these cells to undergo a form of cellular suicide known as programmed necrosis. This helps us to understand how different forms of toxins alter host cell signaling to help S. pyogenes cause different types of diseases.

Indexed as

Cell DeathBacterial ToxinsEpithelial CellsHeLa CellsHumansMitogen-Activated Protein Kinase 8NAD+ NucleosidaseSignal TransductionStreptococcus pyogenesBacterial ToxinsMitogen-Activated Protein Kinase 8NAD+ Nucleosidase

Identifiers

PMID26838722
PMCPMC4742715
OpenAlexW2254674516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.